ArticleInternational journal of molecular sciences2025
scANMF: Prior Knowledge and Graph-Regularized NMF for Accurate Cell Type Annotation in scRNA-seq.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Single-cell RNA sequencing (scRNA-seq) provides a high-resolution view of cellular heterogeneity, yet accurate cell-type annotation remains challenging due to data sparsity, technical noise, and variability across tissues, platforms, and species. Many existing annotation tools depend on a single form of prior knowledge, such as marker genes or reference profiles, which can limit performance when these resources are incomplete or inconsistent. Here, we present scANMF, a prior- and graph-regularized non-negative matrix factorization framework that integrates marker-gene information, partial label supervision, and the local manifold structure into a unified annotation model. scANMF factorizes the expression matrix into interpretable gene-factor and cell-factor representations, enabling accurate annotation in settings with limited or noisy prior information. Across multiple real scRNA-seq collections, scANMF achieved a high annotation accuracy in within-dataset, cross-platform, and cross-species evaluations. The method remained stable under varying levels of label sparsity and marker-gene noise and showed a broad robustness to hyperparameter choices. Ablation analyses indicated that marker priors, label supervision, and graph regularization contribute complementary information to the overall performance. These results support scANMF as a practical and robust framework for single-cell annotation, particularly in applications where high-quality prior knowledge is restricted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.